Chemotherapy for newly diagnosed inoperable brain metastases from non-small cell lung cancer
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness of chemotherapy in patients with newly diagnosed inoperable brain metastases (BM) from non‐small cell lung cancer (NSCLC) in terms of brain response rate, overall survival (OS), progre...
Gespeichert in:
Veröffentlicht in: | Cochrane database of systematic reviews 2018-12, Vol.2018 (12) |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effectiveness of chemotherapy in patients with newly diagnosed inoperable brain metastases (BM) from non‐small cell lung cancer (NSCLC) in terms of brain response rate, overall survival (OS), progression‐free survival (PFS), health‐related quality of life (HRQoL) and treatment related toxic events. |
---|---|
ISSN: | 1465-1858 1465-1858 1469-493X |
DOI: | 10.1002/14651858.CD011141.pub2 |